What is the Return on Assets (ROA) of Chimerix this year?
The Return on Assets (ROA) of Chimerix is -0.39 undefined this year.
Chimerix ROA 2024
Chimerix ROA
-0.39
Ticker
CMRX
ISIN
US16934W1062
WKN
A1T65B
In 2024, Chimerix's return on assets (ROA) was -0.39, a -162.59% increase from the 0.62 ROA in the previous year.
Chimerix Aktienanalyse
What does Chimerix do?
Chimerix Inc is a biopharmaceutical company focused on the development of antiviral drugs. The company was founded in 2002 and is headquartered in Durham, North Carolina. The history of Chimerix dates back to the research of Dr. George Painter, a renowned scientist in the field of antiviral therapy. He discovered that a certain group of molecules, known as nucleoside analogues, have antiviral properties. The idea was to use these molecules as a starting point for the development of drugs that specifically target viruses. The core idea of Chimerix was to create a new business model that is different from traditional pharmaceutical companies. Instead of focusing on the lengthy and costly development of new compounds, the company wanted to utilize existing molecules and create new drugs through targeted modifications. This approach was not only expected to be faster and cost-effective but also to offer higher chances of success. Chimerix is divided into several business segments. The most important segment is antiviral therapy, where the company focuses on developing drugs against various viruses such as Cytomegalovirus (CMV), Adenovirus, and Herpesvirus. Another business segment of Chimerix is oncology. Here, the company also relies on modifying existing compounds to develop new and effective cancer drugs. One promising molecule currently being developed is Brincidofovir, which not only has antiviral properties but also possesses antitumor properties. In addition to drug development, Chimerix also offers support for clinical trials. The company collaborates with various research institutions and biopharmaceutical companies to test the efficacy and safety of new compounds. The most well-known product of Chimerix is Brincidofovir. This antiviral drug is currently being tested in clinical trials and has the potential to be used against a range of viruses. Its use is particularly promising in patients undergoing immunosuppressive therapy, such as those after a stem cell transplant. Chimerix aims to develop innovative and effective drugs that help patients overcome serious diseases. With its unique business model and close collaboration with the research community, the company has already made promising progress and is an important player in the field of antiviral therapy and oncology. Chimerix ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Chimerix's Return on Assets (ROA)
Chimerix's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Chimerix's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Chimerix's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Chimerix’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Chimerix Stock
What was the ROA of Chimerix compared to the previous year?
The ROA of Chimerix has increased by -162.59% compared to the previous year.
What consequences do high ROA have for investors of Chimerix?
A high ROA is advantageous for investors of Chimerix, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Chimerix?
A low ROA can be unfavorable for investors of Chimerix as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Chimerix affect the company?
An increase in ROA of Chimerix can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Chimerix impact the company?
A reduction in the ROA of Chimerix can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Chimerix?
Some factors that can influence the ROA of Chimerix include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Chimerix important for investors?
The ROA of Chimerix is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Chimerix take to improve ROA?
To improve ROA, Chimerix can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Chimerix pay?
Over the past 12 months, Chimerix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chimerix is expected to pay a dividend of 0 USD.
What is the dividend yield of Chimerix?
The current dividend yield of Chimerix is .
When does Chimerix pay dividends?
Chimerix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Chimerix?
Chimerix paid dividends every year for the past 0 years.
What is the dividend of Chimerix?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Chimerix located?
Chimerix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Chimerix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Chimerix from 6/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.
When did Chimerix pay the last dividend?
The last dividend was paid out on 6/19/2024.
What was the dividend of Chimerix in the year 2023?
In the year 2023, Chimerix distributed 0 USD as dividends.
In which currency does Chimerix pay out the dividend?
The dividends of Chimerix are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Chimerix
Our stock analysis for Chimerix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chimerix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
